Endothelial function and arterial stiffness in uncomplicated Type 1 diabetes and healthy controls and the impact of insulin on these parameters During an euglycemic clamp

Journal of Diabetes Science and Technology

Volumn 1, Issue 4, 2007, Pages 582-589

  Wilhelm, Birgit ^a,b   Weber, Matthias M ^c   Kreisselmeier, Hans Peter ^c   Kugler, Matthias ^a   Ries, Claudius ^a   Pfützner, Andreas ^a   Kann, Peter H ^b   Forst, Thomas ^a,c  

^a Institute for Clinical Research and Development   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

ADMA; Augmentation; Augmentation index; Diabetes mellitus type 1; Endothelial function; Nitrotyrosine

Indexed keywords

EID: 74249121488     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100417     Document Type: Article

References (48)

1. Letho S, Rönnemaa T, Pyoräkä K, Laakso M. Poor glygemic controls predicts heart disease events in patients with type 1 diabetes without nephropathy. Aterioscler Thromb Vasc Biol. 1999;19:1014-19.
2. Asmar R, Benetos A, London G, Hugue C, Weiss Y, Topouchian J. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press. 1995;4:48-54.
3. ÓRourke M. Mechanical principles in arterial disease. Hypertension. 1995;26:2-9.
4. Nichols WW, ÓRourke MF. McDonalds blood flow in arteries. Theoretical, experimental and clinical principles. 4th ed. London: Edward Arnold; 1998.
5. ÓRourke MF, Mancia G; Arterial stiffness. J Hypertens. 1999;17:1-4.
6. Berry KL, Skyrme-Jones RA, Cameron JD, ÓBrien RC, Meredith IT. Systemic arterial compliance is reduced in young patients with IDDM. Am J Physiol. 1999;276:H1839-45.
7. Hu J, Wallentsteen M, Genser G. Increased stiffness of the aorta in children and adolescents with insulin-dependent diabetes mellitus. Ultrasound Med Biol. 1996;22:537-43.
8. Oxlund H, Rasmussen LM, Andreassen TT, Heikendorff L. Increased aortic stiffness in patients with type 1 (insulindependent) diabetes mellitus. Diabetologia. 1989;32:748-52.
9. Christensen T, Neubauer B. Increased arterial wall stiffness and thickness in medium-sized arteries in patients with insulindependent diabetes mellitus. Acta Radiol. 1988;29:299-302.
10. Ryden-Ahlgren A, Lanne T, Wollmer P, Sonesson B, Hansen F, Sundkvist G. Increased arterial stiffness in women, but not in men with IDDM. Diabetologica. 1995;38:1082-9.
11. Giannattasio G, Failla M, Piperno A, Grappiolo A, Gamba P, Paleari F, Mancia G. Early impairment of large artery structure and function in type 1 diabetes mellitus. Diabetologica. 1999;42:987-94.
12. Westerbacka J, Uosukainen A, Mäkimattila S, Schlenzka A, Yki-Järvinen H. Insulin-induced decrease in large artery stiffness is impaired in uncomplicated type 1 diabetes mellitus. Hypertension. 2000;35:1043-8.
13. Jensen-Urstad KF, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT. Early artheriosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes. 1996;45:1253-8.
14. De Jongh RT, Clark AD, Izerman RG, Serne EH, De Vries G, Stehouwer CD. Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteers. Int J Obes Relat Metab Disord. 2004;47:978-86.
15. Steinberg HO. Insulin effects on blood flow. Curr Opin Endocrinol Diabetes. 1999;6:135-40.
16. Vehkavaara S, Makimattila S, Schlenzka A, Vakkilainen J, Westerbacka J, Yki-Jarvinen H. Insulin therapy improves endothelial function in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2000;20(2):545-50.
17. Poldermann KH, Stehouwer C D A, Van Kamp GJ, Gooren L J G. Effects of insulin infusion on endothelium-derived vasoactive substances. Diabetologia. 1996;39:1284-92.
18. Flynn MD, Boolell M, Tooke JE, Watkins PJ. The effect of insulin infusion on capillary blood fow in the diabetic neuropathic foot. Diabet Med. 1992;9:630-4.
19. Tooke JE, Lins PE, Ostergren J, Adamson U, Fagrell B. The effects of intravenous insulin infusion on skin microcirculatory fow in type 1 diabetes. Int J Microcirc Clin Exp. 1985;4:69-83.
20. Westerbacka J, Wilkinson I, Cockcroft J, Utrianen T, Vehkavaara S, Yki-Järvinene H. Diminished wave refection in the aorta: a novel physiological action of insulin on large blood vessels. Hypertension. 1999;33:1118-23.
21. ÓRourke MF, Gallgagher DE. Pulse wave analysis. J Hypertens Suppl. 1996;14:147-57.
22. Wilkinson IB, Crockfort JR, Webb DJ. Pulse wave analysis and arterial stiffness. J Cardiovasc Pharmacol. 1998;32:S33-7.
23. Filiposvsky J, Svobodova V, Pecen L. Reproducibility of radial pulse wave analysis in healthy subjects. J Hypertens. 2000;18:1033-40.
24. Wilkinson IB, MacCullum H, Rooijans DF, Murray GD, Crockfort JR, Scanlon MF. Increased augmentation index and systolic stress in type 1 diabetes. QJM. 2000;93:441-8.
25. Smith JC, Page MD, John R, Wheeler MH, Crockfort JR, Scanlon MF. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2000;85:3515-9.
26. Kohara J, Jiang Y, Igase M, Hiwada K. Effect of reflection of arterial pressure on caroid circulation in essential hypertension. Am J Hypertens. 1999;12:1015-20.
27. Chen CH, Nevo E, Fetics B. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of a generalized transfer function. Circulation. 1997;95:1827-36.
28. Pauca AL, ÓRourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial arterial pressure waveform. Hypertension. 2001;38:932-7.
29. ÓRourke MF, Kon ND. Generation of ascending aortic from radial artery pressure wavefrom. J Am Coll Cardiol. 2002;39 Suppl B: 177B.
30. Wilkinson IB, MacCullum H, Flint L. The infuence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525:63-270.
31. Scharm MT, Henry R M A, Van Djik R A J M, Kotense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N, Stehouwer C D A. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes. Hypertension. 2004;43:176-81.
32. Joshua IC, Zhang Q, Falcone JC, Bratcher AP, Rodriguez WE, Tyagi SC. Mechanisms of endothelial dysfuction with development of type 1 diabetes mellitus: role of insulin and c-peptide. J Cell Biochem. 2005;96:1149-56.
33. Weber T, Maas R, Auer J, Lamm G, Lassnig E, Rammer M, ÓRourke MF, Boger RH, Eber B. Arterial wave refections and determinants of endothelial function as hypothesis based on peripheral mode of action. Am J. Hypertension. 2007;20:256-62.
34. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic β cells. Diabetolgica. 1996;39:875-90.
35. Ceriello A, Mercuri F, Qualiaro L, Motz E, Tonutti L, Toboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologica. 2001;44:834-8.
36. Giugliano D, Cervello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-67.
37. Hoeldtke, RD, Bryner KD, McNeil DR, Wareshime SS, Van Dyke K, Hobbs G. Oxidative stress and insulin requirements in patients with recent-onsent type 1 diabetes. JCEM. 2003;88:1624-8.
38. Ceriello A, Qualiaro L, Catone B, Pascon R, Piazzola DS, Bais B, Marra G, Tonutti L, Toboga C, Motz E. Role of hyperglycemia in nitrotyrosine generation. Diabetes Care. 2002;25:1439-43.
39. Martella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest. 2001;108:635-6.
40. Kamata K, Miyata N, Abiru T, Kasuya J. Functional changes in the vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci. 1992;50:1379-87.
41. Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Godeva L, Schmidt-Lucke C, Kusus M, Maas R, Schedhelm E, Strodter D, Simon BC, Mugge A, Daniel WG, Tillmanns H, Maisch B, Streichert T, Boger RH. Asymmetric dimethylarginine is an independent risk factor coronary heart disease: results from the multicenter Coronary Artery Risk Determination investing the infuence of ADMA Concentration (CARDIAC) study. Am Heart J. 2006;152:e1-8.
42. Cooke JP. ADMA: its role in vascular disease. Vasc Med. 2005;10(Suppl 1):S11-7.
43. Sydow K, Mondon CE, Cooke J P. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med. 2005;10(Suppl 1):S35-43.
44. Takiuchi S, Fujii H, Kamide K, Horio T, Nakatani S, Hiuge A, Rakugi H, Ogihara T, Kawano Y. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial function in hypertensive patients. Am J Hypertens. 2004;17:802-8.
45. Lin KY, Asagami T Tsao PS, Adimoolam S Kimoto M, Tsuji H, Reaven GM, Cooke JP. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation. 2002;106:987-92.
46. Abbassi F, Asagami T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuhlinger MC, Tsao PS. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol. 2001;88:1201-3.
47. Stulinger MC, Abbassi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM Tsao PS. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002;287:1420-6.
48. Tarnow L, Hovind P, Teerlink T, Stehouwer C A D, Pariving HH. Elevated plasma asymetric dimethylarginine as marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care. 2004;27:765-9.